(LARS) Score Validation of Turkish Language
- Conditions
- LARS - Low Anterior Resection Syndrome
- Registration Number
- NCT05289531
- Lead Sponsor
- Ankara University
- Brief Summary
Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and its impact on quality of life in Danish patients. Recently, English and many other language versions have been validated. The aim of this study was to validate the Turkish translation of the LARS score in Turkish patients who have undergone treatment for rectal cancer.
- Detailed Description
A total of 326 patients were reviewed and contacted for the study, and 222 (68%) were eligible for the analyses. The association between the LARS score and quality of life and the test-retest reliability were studied. The intraclass correlation coefficient (ICC) was calculated to understand the degree of reliability.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 222
The inclusion criteria were
- rectal adenocarcinoma within 15 cm from the anal verge
- LAR with either PME or TME.
- Bowel continuity restored for at least 18 months when invited for the study.
Exclusion criteria included
- failed R0 surgery,
- recurrence or dissemination,
- having intestinal stoma,
- previous cancer (except minor skin cancers)
- dementia and inability to speak Turkish (i.e., the need for a translator during treatment).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validity of LARS Score From Feb 2016 to Feb 2020 The translated questionaire was validated on Turkish speaking patients
- Secondary Outcome Measures
Name Time Method